Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Ipsen Limited
Femme et Homme Max 99 ans
Ipsen Limited
MAJ Il y a 4 ans
A Phase IV (post marketing), multicentre, open label, single group study to look at the clinical value of counting Circulating Tumour Cells in order to predict the clinical response in patients receiving deep injections of Somatuline Autogel into the fat layer of the skin to treat the symptoms of functioning Neuroendocrine Tumours (tumours which secrete hormones) which are located in the intestines
The principal objective in the study is to assess whether counting the number of circulating tumour cells (CTCs) in the bloodstream of patients with functioning neuroendocrine tumours (NETs) (tumours ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme Max 99 ans
Ipsen Limited
MAJ Il y a 4 ans
A phase II, international, multi-centre, prospective, randomised, parallel-group, double-blind, dose-ranging, placebo-controlled, 12-week, princeps study to assess the efficacy and safety of a one injection cycle with either botulinum toxin Type-A (Dysport® 125, 250 or 500 Units) or placebo followed by an optional 6-month extension phase in the symptomatic treatment of micturition urgency and frequency in continent female subjects suffering from idiopathic overative bladder
To assess the effect of treatment with three doses of botulinum toxin type-A (Dysport®) versus placebo on the number of episodes of urgency and frequency of micturition experienced in continent female...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations